Lloyd Mitchell Segal insider trades: Repare Therapeutics (RPTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lloyd reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | RPTX | ↓ Sell | 21,179 | $1.14 | $24K | Direct | Mar 14, 2025 (2d) |
| Apr 1, 2024 | RPTX | ↓ Sell | 5,141 | $4.62 | $24K | Indirect | Apr 1, 2024 (0d) |
| Mar 27, 2024 | RPTX | ↓ Sell | 7,950 | $4.69 | $37K | Indirect | Mar 27, 2024 (0d) |
| Jun 28, 2021 | RPTX | ↓ Sell | 1,542 | $35.61 | $55K | Indirect | Jun 30, 2021 (2d) |
| Jun 9, 2021 | RPTX | ↓ Sell | 1,576 | $35.00 | $55K | Indirect | Jun 10, 2021 (1d) |
| Jun 4, 2021 | RPTX | ↓ Sell | 36,000 | $31.09 | $1.1M | Indirect | Jun 7, 2021 (3d) |
| Jun 4, 2021 | RPTX | ↓ Sell | 5,000 | $31.25 | $156K | Direct | Jun 7, 2021 (3d) |
| May 20, 2021 | RPTX | ↓ Sell | 3,770 | $35.03 | $132K | Indirect | May 21, 2021 (1d) |
| May 19, 2021 | RPTX | ↓ Sell | 5,600 | $35.04 | $196K | Indirect | May 20, 2021 (1d) |
| Apr 15, 2021 | RPTX | ↓ Sell | 5,512 | $35.01 | $193K | Indirect | Apr 19, 2021 (4d) |
| Jun 23, 2020 | RPTX | ↑ Buy | 5,000 | $20.00 | $100K | Direct | Jun 25, 2020 (2d) |
| Jun 14, 2013 | VRX | ↑ Buy | 140 | $85.45 | $12K | Direct | Jun 18, 2013 (4d) |
| Jun 12, 2013 | VRX | ↑ Buy | 2,800 | $83.85 | $235K | Direct | Jun 13, 2013 (1d) |
| Jun 11, 2013 | VRX | ↑ Buy | 390 | $86.45 | $34K | By Wife | Jun 13, 2013 (2d) |
| Nov 9, 2012 | VRX | ↑ Buy | 240 | $54.28 | $13K | By Wife | Nov 14, 2012 (5d) |
| Nov 9, 2012 | VRX | ↑ Buy | 240 | $54.28 | $13K | By Wife | Nov 14, 2012 (5d) |
| Nov 6, 2012 | VRX | ↑ Buy | 745 | $54.44 | $41K | Direct | Nov 8, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Lloyd Mitchell Segal's insider trades
Lloyd Mitchell Segal is President and CEO at Repare Therapeutics (RPTX). Since Nov 6, 2012, Lloyd has reported 7 open-market purchases worth $447K and 10 sales worth $2.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), option exercises (2 filings), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RPTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.